This paper analyzes the structural consequences of health insurance consolidation in the United States, focusing on its effects on medical innovation, clinical autonomy, and private sector care capacity. It proposes a decentralized solution architecture that separates innovation approval from centralized risk pooling, introducing parallel approval lanes, bounded risk corridors, opt in micro premiums, outcomes-based reimbursement, and restored provider autonomy. The framework is designed to preserve insurer profitability while expanding patient access and enabling sustainable innovation.
Kearon Allen (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: